Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

PKD2 antibody (C-Term)

PKD2 Reactivity: Human WB, IHC (p) Host: Rabbit Polyclonal unconjugated
Catalog No. ABIN543268
  • Target See all PKD2 Antibodies
    PKD2 (Polycystic Kidney Disease 2 (Autosomal Dominant) (PKD2))
    Binding Specificity
    • 15
    • 13
    • 10
    • 8
    • 7
    • 5
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    C-Term
    Reactivity
    • 63
    • 53
    • 19
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Human
    Host
    • 70
    • 3
    • 1
    Rabbit
    Clonality
    • 72
    • 3
    Polyclonal
    Conjugate
    • 38
    • 6
    • 5
    • 5
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    This PKD2 antibody is un-conjugated
    Application
    • 41
    • 40
    • 13
    • 13
    • 9
    • 8
    • 7
    • 5
    • 3
    • 2
    • 2
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
    Purpose
    Rabbit polyclonal antibody raised against synthetic peptide of PKD2.
    Cross-Reactivity
    Human
    Immunogen
    A synthetic peptide (conjugated with KLH) corresponding to C-terminus of human PKD2.
    Top Product
    Discover our top product PKD2 Primary Antibody
  • Application Notes
    Western Blot (1:1000)
    Immunohistochemistry (1:50-100)
    The optimal working dilution should be determined by the end user.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    In PBS (0.09 % sodium azide)
    Preservative
    Sodium azide
    Precaution of Use
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    4 °C,-20 °C
    Storage Comment
    Store at 4°C. For long term storage store at -20°C.
    Aliquot to avoid repeated freezing and thawing.
  • Gargalionis, Korkolopoulou, Farmaki, Piperi, Dalagiorgou, Adamopoulos, Levidou, Saetta, Fragkou, Tsioli, Kiaris, Zizi-Serbetzoglou, Karavokyros, Papavassiliou, Tsavaris, Patsouris, Basdra et al.: "Polycystin-1 and polycystin-2 are involved in the acquisition of aggressive phenotypes in colorectal cancer. ..." in: International journal of cancer. Journal international du cancer, Vol. 136, Issue 7, pp. 1515-27, (2015) (PubMed).

    Varela, Piperi, Sigala, Agrogiannis, Davos, Andri, Manopoulos, Tsangaris, Basdra, Papavassiliou: "Elevated expression of mechanosensory polycystins in human carotid atherosclerotic plaques: association with p53 activation and disease severity." in: Scientific reports, Vol. 5, pp. 13461, (2015) (PubMed).

    Stayner, Zhou: "Polycystin channels and kidney disease." in: Trends in pharmacological sciences, Vol. 22, Issue 11, pp. 543-6, (2001) (PubMed).

    Watnick, He, Wang, Liang, Parfrey, Hefferton, St George-Hyslop, Germino, Pei: "Mutations of PKD1 in ADPKD2 cysts suggest a pathogenic effect of trans-heterozygous mutations." in: Nature genetics, Vol. 25, Issue 2, pp. 143-4, (2000) (PubMed).

    Lehtonen, Ora, Olkkonen, Geng, Zerial, Somlo, Lehtonen: "In vivo interaction of the adapter protein CD2-associated protein with the type 2 polycystic kidney disease protein, polycystin-2." in: The Journal of biological chemistry, Vol. 275, Issue 42, pp. 32888-93, (2000) (PubMed).

  • Target
    PKD2 (Polycystic Kidney Disease 2 (Autosomal Dominant) (PKD2))
    Alternative Name
    PKD2 (PKD2 Products)
    Synonyms
    APKD2 antibody, PC2 antibody, PKD4 antibody, Pc-2 antibody, TRPP2 antibody, C030034P18Rik antibody, RGD1559992 antibody, pkd2 antibody, trpp2 antibody, Cup antibody, PKD2L1 antibody, polycystin 2, transient receptor potential cation channel antibody, polycystic kidney disease 2 antibody, Polycystin-2 antibody, polycystin 2, transient receptor potential cation channel L homeolog antibody, PKD2 antibody, Pkd2 antibody, pkd-2 antibody, pkd2.L antibody, pkd2 antibody
    Gene ID
    5311
    Pathways
    cAMP Metabolic Process, Maintenance of Protein Location, Negative Regulation of Transporter Activity
You are here:
Support